Bahrain vs Italy: Cause of death, by non-communicable diseases, ages 60+, male
Bahrain
80.5%
in 2021
Italy
80.7%
in 2021
Bahrain rank
38th
Italy rank
37th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Bahrain
- Italy
How they compare
Italy currently reports 80.7% against 80.5% in Bahrain, a difference of 0.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Italy ahead.
Bahrain ranks 38th and Italy ranks 37th of 185 countries.
Across the 3 decades both report, Bahrain averaged higher in 2 and Italy in 1.
Head to head by decade
| Decade | Bahrain | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.8% | 94.0% | 1.2% | Italy |
| 2010s | 93.7% | 92.4% | 1.2% | Bahrain |
| 2020s | 83.1% | 80.1% | 3.0% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Bahrain or Italy?
- Italy, at 80.7% against 80.5% in Bahrain as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Bahrain and Italy?
- 0.2%, with Italy ahead.
- How many years of comparable data are there for Bahrain and Italy?
- 6 years are reported by both, from 2000 to 2021.
- How do Bahrain and Italy rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Bahrain ranks 38th and Italy ranks 37th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.